These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9286199)

  • 1. Fluvoxamine-induced theophylline toxicity.
    DeVane CL; Markowitz JS; Hardesty SJ; Mundy S; Gill HS
    Am J Psychiatry; 1997 Sep; 154(9):1317-8. PubMed ID: 9286199
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic effects of theophylline caused by fluvoxamine.
    van den Brekel AM; Harrington L
    CMAJ; 1994 Nov; 151(9):1289-90. PubMed ID: 7954177
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of fluvoxamine-induced anorgasmia with a partial drug holiday.
    Németh A; Arató M; Treuer T; Vandlik E
    Am J Psychiatry; 1996 Oct; 153(10):1365. PubMed ID: 8831451
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxic interaction between fluvoxamine and sustained release theophylline in an 11-year-old boy.
    Sperber AD
    Drug Saf; 1991; 6(6):460-2. PubMed ID: 1793525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of serotonin uptake inhibitors: focus on fluvoxamine.
    Hrdina PD
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):10-8. PubMed ID: 1931931
    [No Abstract]   [Full Text] [Related]  

  • 6. Probable metabolic interaction between methadone and fluvoxamine in addict patients.
    Bertschy G; Baumann P; Eap CB; Baettig D
    Ther Drug Monit; 1994 Feb; 16(1):42-5. PubMed ID: 8160253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EPMS under antidepressive therapy with fluvoxamine and concomitant antibiotic therapy with clindamycin.
    Jakob F; Wolf J
    Pharmacopsychiatry; 2007 May; 40(3):129. PubMed ID: 17541891
    [No Abstract]   [Full Text] [Related]  

  • 8. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
    Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dyskinesia associated with fluvoxamine.
    Arya DK; Szabadi E
    J Clin Psychopharmacol; 1993 Oct; 13(5):365-6. PubMed ID: 8227498
    [No Abstract]   [Full Text] [Related]  

  • 10. Extrapyramidal symptoms in a patient treated with fluvoxamine.
    Wils V
    J Neurol Neurosurg Psychiatry; 1992 Apr; 55(4):330-1. PubMed ID: 1583525
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of fluvoxamine intoxication demonstrating nonlinear elimination pharmacokinetics.
    Spigset O; Ohman R
    J Clin Psychopharmacol; 1996 Jun; 16(3):254-5. PubMed ID: 8784660
    [No Abstract]   [Full Text] [Related]  

  • 12. Polydipsia induced by fluvoxamine.
    Benazzi F; Mazzoli M
    Pharmacopsychiatry; 1993 Mar; 26(2):63. PubMed ID: 8378415
    [No Abstract]   [Full Text] [Related]  

  • 13. Fluvoxamine-induced acute exacerbation in residual schizophrenia.
    Rocco PL; De Leo D
    Pharmacopsychiatry; 1992 Sep; 25(5):245. PubMed ID: 1409869
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy.
    Miljković BR; Pokrajac M; Timotijević I; Varagić V
    Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in clinical effect and tolerance between fluvoxamine and paroxetine: a switching study in patients with depression.
    Suzuki Y; Tsuneyama N; Fukui N; Sugai T; Watanabe J; Ono S; Someya T
    Hum Psychopharmacol; 2010 Nov; 25(7-8):525-9. PubMed ID: 20860067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of fluvoxamine-induced anorgasmia by cyproheptadine.
    Arnott S; Nutt D
    Br J Psychiatry; 1994 Jun; 164(6):838-9. PubMed ID: 7952994
    [No Abstract]   [Full Text] [Related]  

  • 17. Theophylline-isoniazid interaction.
    Torrent J; Izquierdo I; Cabezas R; Jané F
    DICP; 1989 Feb; 23(2):143-5. PubMed ID: 2728504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interactions of theophylline and H2 receptor antagonists. Interaction modes--clinical relevance].
    Beier W; Kaukel E
    Fortschr Med; 1992 Mar; 110(9):158-60. PubMed ID: 1351026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline toxicity after propafenone treatment: evidence for drug interaction.
    Lee BL; Dohrmann ML
    Clin Pharmacol Ther; 1992 Mar; 51(3):353-5. PubMed ID: 1544292
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluvoxamine: clinical trials and clinical use.
    Freeman CP
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):19-25. PubMed ID: 1931932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.